Literature DB >> 1285360

The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man.

G Tallroth1, E Ryding, R Ekman, C D Agardh.   

Abstract

The changes in plasma gastrin-releasing peptide (GRP), arginine vasopressin (AVP), neuropeptide Y (NPY), corticotropin releasing hormone (CRH), galanin, ACTH, cortisol, delta sleep-inducing peptide (DSIP), adrenaline, noradrenaline and pancreatic polypeptide (PP) were measured after 5 and 15 minutes of acute insulin-induced moderate hypoglycaemia (2.0 mmol/l) in 10 patients with Type 1 diabetes mellitus with no autonomic neuropathy and in 10 healthy subjects. Plasma catecholamine and PP levels rose in both groups in response to hypoglycemia and the secretory response of ACTH was lower in the diabetic subjects (p < 0.01). GRP concentrations increased during hypoglycaemia (p < 0.01) while a reduction in AVP occurred at the start of hypoglycaemia (p < 0.001). The plasma AVP concentrations were higher in the diabetic group compared with those in the normal group (p < 0.05). The NPY concentrations were higher in the normal subjects (p < 0.05) but no change in the mean level occurred in either group during hypoglycaemia. No group differences or changes in mean plasma concentrations were found for galanin, DSIP and CRH. These observations support the view that regulatory peptides, if involved in glucose homeostasis, may rather have a modulatory effect than a direct action in restoring normoglycaemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285360

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  6 in total

1.  Plasma neuropeptide Y in impaired glucose tolerance.

Authors:  B Ahrén; H Larsson
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

2.  Neuropeptide Y secretion from a human insulinoma.

Authors:  G Waeber; J Hurlimann; J A Haefliger; F Gomez; P Nicod; E Grouzmann
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

3.  Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33).

Authors:  W E Boertien; I J Riphagen; I Drion; A Alkhalaf; S J L Bakker; K H Groenier; J Struck; P E de Jong; H J G Bilo; N Kleefstra; R T Gansevoort
Journal:  Diabetologia       Date:  2013-04-28       Impact factor: 10.122

4.  Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.

Authors:  P Bardoux; H Martin; M Ahloulay; F Schmitt; N Bouby; M M Trinh-Trang-Tan; L Bankir
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption.

Authors:  Jessica Y S Chu; Samuel C K Chung; Amy K M Lam; Sidney Tam; Sookja K Chung; Billy K C Chow
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

Review 6.  Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs; Kristen J Nadeau
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.